COMMUNIQUÉS West-GlobeNewswire

May 2024 Letter to Shareholders
16/05/2024
VANCOUVER, Washington, May 16, 2024 (GLOBE NEWSWIRE) -- Dear Shareholders, I write today to provide an update on CytoDyn Inc. (“CytoDyn” or “Company”), as we approach the end of our 2024 fiscal year (May 31, 2024), and [...]
Femasys CEO and Founder Kathy Lee-Sepsick Meets with the White House’s Gender Policy Council
16/05/2024
Lee-Sepsick Discussed Atlanta-Based Biomedical Company’s Women’s Reproductive Health Products ATLANTA, May 16, 2024 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical company focused on addressing [...]
Assure Announces Approval of Increase in Authorized Capital at Adjourned Special Shareholders Meeting
16/05/2024
DENVER, May 16, 2024 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, announced today that at its [...]
GLUCOTRACK’S EPIDURAL GLUCOSE MONITORING SENSOR DEMONSTRATES SUCCESSFUL 30-DAY SAFETY & PERFORMANCE IN LONG-TERM PRECLINICAL STUDY
16/05/2024
Promising results support the potential of epidural glucose monitoring for simplified disease management for patients with painful diabetic neuropathy Rutherford, NJ, May 16, 2024 (GLOBE NEWSWIRE) -- Glucotrack, Inc. ( [...]
Claritas HealthTech Extends Claritas iPET™ capability with iPETcertum™ for Automated Lesion Detection and Quantification of Isotope Uptake in PET Scans
16/05/2024
LONDON and NEW YORK and TORONTO, May 16, 2024 (GLOBE NEWSWIRE) -- Claritas HealthTech Ltd, a company specializing in state-of-the-art image enhancement, reconstruction, and AI solutions for the medical industry, is [...]
NKGen Biotech Announces Upcoming Presentation on Autologous NK Cell Therapy at the 5th International Cell & Gene Therapy China Summit & Exhibition
16/05/2024
SANTA ANA, Calif., May 16, 2024 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (Nasdaq: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of innovative [...]
MatrixCare Joins Health Gorilla’s Qualified Health Information Network (QHIN) to Enhance Patient Data Access
16/05/2024
The alliance with Health Gorilla will provide MatrixCare customers with more than 220 million patient records to streamline workflows and improve patient outcomes. BLOOMINGTON, Minn., May 16, 2024 (GLOBE NEWSWIRE) -- [...]
Ardelyx Presents Additional Data at the NKF 2024 Spring Clinical Meetings on XPHOZAH® (tenapanor)
16/05/2024
WALTHAM, Mass., May 16, 2024 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet [...]
Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Patent Allowance for Malaria Antibodies That Have Potential Capability to Protect Against Infection and Treat Severe Disease
16/05/2024
Providence, RI, May 16, 2024 (GLOBE NEWSWIRE) -- Ocean Biomedical (NASDAQ: OCEA ) announced today that Scientific Co-founder Dr. Jonathan Kurtis, MD, PhD, has been granted a new patent for his malaria therapeutic [...]
Fortress Biotech to Participate in the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company Showcase
16/05/2024
MIAMI, May 16, 2024 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on acquiring and advancing assets to enhance long-term value for shareholders [...]
Sagimet Biosciences to Host Virtual Investor and Analyst Day on Inhibiting Fatty Acid Synthase (FASN) to Reduce Liver Fat, Inflammation and Fibrosis in MASH on May 23, 2024
16/05/2024
Dr. Scott Friedman to present unmet need in MASH and discuss Sagimet’s topline data from its FASCINATE-2 Phase 2b clinical trial of denifanstat in MASH SAN MATEO, Calif., May 16, 2024 (GLOBE NEWSWIRE) -- Sagimet [...]
Akari Therapeutics Reports First Quarter 2024 Financial Results and Recent Highlights
16/05/2024
Entered into a Definitive Merger Agreement with Peak Bio; Expected to Close in the Third Quarter of 2024 Samir R. Patel, M.D. Appointed Interim CEO Plan for Prioritization of Peak Bio’s ADC Cancer Therapeutic Platform [...]
Halo Dental Technologies Opens Waitlist for Its New Digital Mirror at California Dental Association Annual Conference
16/05/2024
Waitlist for the first-of-its-kind digital dental mirror opens May 16, 2024, for dentists and hygienists who want to be among the first to secure the Halo Digital Mirror MONTREAL, May 16, 2024 (GLOBE NEWSWIRE) -- Halo [...]
BeyondSpring R&D Day Highlights New Plinabulin Development Strategy for Cancer and Updates for SEED Therapeutics
16/05/2024
FLORHAM PARK, N.J., May 16, 2024 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI) (“BeyondSpring” or the “Company”), a clinical-stage global biopharmaceutical company focused on developing innovative cancer [...]
Totus Medicines Announces Strategic Multi-Target Research Collaboration with Lilly
16/05/2024
Collaboration leverages Totus’ covalent chemistry-based OmniDEL platform for the identification of small molecule drug candidates across multiple therapeutic areas EMERYVILLE, Calif., May 16, 2024 (GLOBE NEWSWIRE) -- [...]
Cannabix Technologies and Omega Laboratories Inc. Enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology
16/05/2024
VANCOUVER, British Columbia, May 16, 2024 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company” or “Cannabix”) reports that it has entered into a strategic [...]
Chiesi to Present New Data Showcasing Depth of Respiratory Leadership at the American Thoracic Society 2024 International Conference
16/05/2024
Presentations will highlight new data in respiratory conditions, including asthma and chronic obstructive pulmonary disease (COPD) Data to be presented include new six-month results from a study of a single-inhaler [...]
Ventyx Biosciences Announces Appointment of Matthew Moore as Chief Operating Officer
16/05/2024
SAN DIEGO, May 16, 2024 (GLOBE NEWSWIRE) -- Ventyx Biosciences, Inc. (Nasdaq: VTYX), (“Ventyx”), a clinical-stage biopharmaceutical company focused on advancing novel oral therapies that address a range of inflammatory [...]
Scorpius Holdings Commends Congress on Bipartisan Legislative Action Aimed at Bolstering U.S. Biomanufacturing
16/05/2024
Urges Congress to Immediately Pass the BIOSECURE Act DURHAM, N.C., May 16, 2024 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (NYSE American: SCPX) (“Scorpius” or “the Company”), an integrated contract development and [...]

Pages